期刊文献+

系统性硬化症的诊治进展 被引量:8

Update of the diagnosis and treatment of systemic sclerosis
下载PDF
导出
摘要 系统性硬化症(systemic sclerosis,SSc)是一类以免疫异常、小血管病变及成纤维细胞功能障碍为主要特点的自身免疫性疾病。严重者可以累及心脏、肺部及肾脏等重要脏器,死亡率及致残率较高,预后差。早期诊断及有效治疗手段有利于提高患者生存率。 Systemic sclerosis is an autoimmune diseases characterized by immune abnormalities,small vascular lesions and fibroblasts dysfunction. Important organs such as heart,lung and kidney can be affected in serious cases. The mortality and morbidity is higher and the prognosis is poor. Early diagnosis and effective treatment are conducive to improve patient's survival.
作者 唐鸿鹄 刘毅
出处 《实用医院临床杂志》 2015年第5期38-42,共5页 Practical Journal of Clinical Medicine
关键词 系统性硬化症 早期诊断 治疗进展 Systemic sclerosis Early diagnosis Treatment
  • 相关文献

参考文献32

  • 1Debendra Pattanaik,Monica Brown,Postlethwaite BC,et al.Patho- genesis of Systemic Sclerosis[J].Front Immunol,2015,6:272.
  • 2Maricq HRjWeinrich MC,Keil JE,et al.Prevalence of scleroderma spectrum disorders in the general population of south Carolina[J]. ArthritisRheum,1989,32(8):998-1006.
  • 3Mayes MD,Lacey JV,Jr,Beebe-Dimmer J,et al.Prevalence,inci- dence,survival,and disease characteristics of systemic sclerosis in a large US population[J].Arthritis Rheum,2003,48(8):2246-2255.
  • 4Steen V,Domsic RT,Lucas M,et al.Jr A clinical and serologic com- parison of african american and caucasian patients with systemic sclerosis[J].Arthritis Rheum,2012,64(9):2986-2994.
  • 5Pattanaik D,Brown M,Postlethwaite AE.Vascular involvement in systemic sclerosis(scleroderma)[J].J Inflamm Res,2011,4:105-25.10.2147/JIR.S18145.
  • 6Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.Prelimi- nary criteria for the classification of systemic sclerosis(sclerdderma)[J].Arthritis Rheum,1980,23:581-590.
  • 7Koenig M,Joyal FjFritzler MJ,et al.Autoantibodies and microvascu- Iar damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis:a twenty-year prospec- tive study of 586 patients,with validation of proposed criteria for ear- ly systemic sclerosis[J].Arthritis Rheum,2008,58:3902-3912.
  • 8Frank van den Hoogen,Dinesh Khannay Jaap Fransen,et al.2013 classification criteria for systemic sclerosis:an American college of rheumatology/European league against riieumatism collaborative ini- tiative[J].Ann Eheum Dis,2013,72:1747-1755.
  • 9Shah AA,Fredrick MHS,Wigley M.My Approach to the Treatment of Scleroderma[J].Mayo Clin Proc,2013,88(4):377-393.
  • 100Kowal-Bielecka,R Landew^,et al.EULAR recommendations for the treatment of systemic sclerosis:a report from the EULAR Sclero- derma Trials and Research group(EUSTAR)[J].Ann Rheum Dis,2009,68:620-628 doi:10.1136/arcl.2008.096677.

同被引文献79

  • 1郭刚,陆春玲.硬皮病从络病论治[J].新中医,2007,39(3):7-9. 被引量:17
  • 2朱佳,曾小峰.沙利度胺在风湿性疾病中的作用[J].中国新药杂志,2007,16(15):1155-1158. 被引量:10
  • 3中华人民共和国卫生部.中药新药临床研究指导原则[S].第二辑.1995.199-201.
  • 4Masi AT, Rodnan GP, Medesger TA. Preliminary criteria for theclassification of systemic sclerosis (sderoderma). Sub- committeefor scleroderma criteria of the American Rheuma- tism AaaoeimionDiagnostic and Therapeutic Criteria Com- mittee [ J ]. ArthritisRheum, 1980,23 ( 5 ) :581 - 590. 277.
  • 5Steen VD, Medsger TA Jr, Rodnan GP. D-Penieillamine therapyin progressive systemic sclerosis ( scleroderma ) : a retrospective analysis[ J]Ann Intern Med, 1982,97 ( 5 ) : 652 - 659.
  • 6Kahan A,Amor B, Menkes C J, et al. Recombinant interferon gamma in the treatment of systemic sclerosis [ J]. Am J Med, 1989,87 ( 3 ) : 273 -.
  • 7Tehlirian CV, Hummers LK, White B, et al. High-dose cy- clophosphamide without stemcell rescue in seleroderma [ J ]. Anals of the rheumatic diseases, 2008,67 ( 6 ) : 775 - 781.
  • 8Krishna SM. $ harm VK, Khaitan BK, et al. Evaluation of o- ral Methotrexate in the trealment of sysntic sclerosis[ J]. In- terna tional journal of Dermatology, 2007,46 (2) : 218 - 223.
  • 9Lehman TJ, Schechter SJ, Sundel RP, et al. Thalidomide for sevcIe systemic onset juvenile rheumatoid atritis a multi- center study[ J]J Pediatr,2004,145:856 - 857.
  • 10Hamuryudan V, Mat C, Salp S, et al. Thalidomide in thetreatment of the mucacutaneous lesions of the Behcet syn- drome : a randomized, doubleblind, placebo, controlled trial [ J ]. Ann InternMed, 1998,128 (6) :443 - 450.

引证文献8

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部